Corcept Therapeutics
CORT
#2700
Rank
โ‚ฌ5.57 B
Marketcap
51,89ย โ‚ฌ
Share price
0.89%
Change (1 day)
-22.44%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): โ‚ฌ5.45 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ0.76 Billion. In 2025 the company made an earning of โ‚ฌ57.27 Million a decrease over its 2024 earnings that were of โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ5.45 M-90.47%
2025 โ‚ฌ57.27 M-58.84%
2024 โ‚ฌ0.13 B29.65%
2023 โ‚ฌ0.10 B7.2%
2022 โ‚ฌ0.10 B-7.05%
2021 โ‚ฌ0.10 B-5.01%
2020 โ‚ฌ0.11 B12.79%
2019 โ‚ฌ0.10 B26.61%
2018 โ‚ฌ79.4 M74.51%
2017 โ‚ฌ45.5 M548.72%
2016 โ‚ฌ7.01 M-227.03%
2015 -โ‚ฌ5.53 Million-79.58%
2014 -โ‚ฌ27.05 Million-31.79%
2013 -โ‚ฌ39.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.38 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.60 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.12 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ26.82 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.33 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.26 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ1.21 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ23.65 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA